Novonesis (Novozymes) B/ DK0060336014 /
11/19/2024 3:23:27 PM | Chg. +4.10 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
395.20DKK | +1.05% | 56,374 Turnover: 21.97 mill. |
-Bid Size: - | -Ask Size: - | 109.76 bill.DKK | 1.06% | 36.25 |
Assets
2016 IFRS in mill. DKK |
2017 IFRS in mill. DKK |
2018 IFRS in mill. DKK |
2019 IFRS in mill. DKK |
2020 IFRS in mill. DKK |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 8,641 | 8,926 | 9,698 | 10,212 | 8,930 | ||||||
Intangible Assets | 1,578 | 2,432 | 2,130 | 1,926 | 2,554 | ||||||
Long-Term Investments | 151 | 29 | 20 | 22 | 21 | ||||||
Fixed Assets | - | - | - | - | - | ||||||
Inventories | 2,488 | 2,586 | 2,820 | 2,613 | 2,361 | ||||||
Accounts Receivable | 2,680 | 2,554 | 2,606 | 2,864 | 2,549 | ||||||
Cash and Cash Equivalents | 812 | 632 | 723 | 711 | 1,181 | ||||||
Current Assets | 6,393 | 6,137 | 6,835 | 6,988 | 6,888 | ||||||
Total Assets | 18,659 | 18,373 | 19,697 | 20,375 | 20,510 |
Liabilities
2016 IFRS in mill. DKK |
2017 IFRS in mill. DKK |
2018 IFRS in mill. DKK |
2019 IFRS in mill. DKK |
2020 IFRS in mill. DKK |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 1,194 | 1,341 | 1,418 | 1,117 | 1,100 | ||||||
Long-term debt | 1,727 | 1,312 | 1,474 | 2,775 | 3,254 | ||||||
Liabilities to Banks | 1,927 | 2,291 | 3,373 | 4,186 | 4,563 | ||||||
Provisions | 1,583 | 1,449 | 1,871 | 1,553 | 1,745 | ||||||
Liabilities | 6,914 | 7,106 | 8,259 | 8,957 | 9,266 | ||||||
Share Capital | 620 | 610 | 594 | 582 | 570 | ||||||
Total Equity | 11,732 | 11,254 | 11,425 | 11,468 | 11,233 | ||||||
Minority Interests | 13 | 13 | 13 | 12 | 11 | ||||||
Total liabilities equity | 18,659 | 18,373 | 19,697 | 20,375 | 20,510 |
Income Statement
2016 IFRS in mill. DKK |
2017 IFRS in mill. DKK |
2018 IFRS in mill. DKK |
2019 IFRS in mill. DKK |
2020 IFRS in mill. DKK |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 14,142 | 14,531 | 14,390 | 14,374 | 14,012 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 3,946 | 4,047 | 4,070 | 4,039 | 3,652 | ||||||
Interest Income | -34 | -157 | -117 | -235 | -127 | ||||||
Income Before Taxes | 3,881 | 3,876 | 3,936 | 3,799 | 3,521 | ||||||
Income Taxes | 831 | 756 | 709 | 644 | 695 | ||||||
Minority Interests Profit | 0.0000 | -1 | -1 | -1 | -1 | ||||||
Net Income | 3,050 | 3,119 | 3,226 | 3,154 | 2,825 |
Per Share
Cash Flow
2016 IFRS in mill. DKK |
2017 IFRS in mill. DKK |
2018 IFRS in mill. DKK |
2019 IFRS in mill. DKK |
2020 IFRS in mill. DKK |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 3,840 | 4,063 | 3,679 | 3,196 | 4,355 | ||||||
Cash Flow from Investing Activities | -1,349 | -1,668 | -1,392 | -561 | -1,524 | ||||||
Cash Flow from Financing | -2,484 | -2,815 | -2,167 | -2,644 | -2,314 | ||||||
Decrease / Increase in Cash | 9 | -442 | 91 | -12 | 470 | ||||||
Employees | 6,441 | 6,245 | 6,427 | 6,125 | 6,185 |